Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused Review

被引：7
|
作者：
Arbit, Boris [1 ]
Hsu, Jonathan C. [1 ]
机构：
[1] Univ Calif San Diego, Dept Med, Div Cardiol, Cardiac Electrophysiol Sect, La Jolla, CA 92093 USA
来源：
CLINICAL CARDIOLOGY | 2015年 / 38卷 / 11期
关键词：
PROTHROMBIN COMPLEX CONCENTRATE; DIRECT THROMBIN INHIBITOR; ACUTE ISCHEMIC-STROKE; PARTIAL THROMBOPLASTIN TIME; RECOMBINANT FACTOR VIIA; FACTOR XA INHIBITOR; DABIGATRAN ETEXILATE; IN-VITRO; LABORATORY MEASUREMENT; COAGULATION ASSAYS;
D O I：
10.1002/clc.22434
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Atrial fibrillation (AF) is the most common cardiac arrhythmia and predisposes patients to an increased risk of embolic stroke. After nearly 60 years, warfarin is no longer the only effective therapeutic option for patients with AF. Large randomized trials have consistently shown that non- vitamin K oral anticoagulants (NOACs) including dabigatran, rivaroxaban, apixaban, and edoxaban significantly reduce from the risk of intracranial hemorrhage (ICH) compared with warfarin. We provide a focused review regarding the NOACs and ICH in AF patients by summarizing findings of these large clinical trials, mechanisms of lower ICH, reversal strategies with specific agents, and monitoring strategies.
引用
收藏
页码：684 / 691
页数：8
相关论文
共 50 条
  • [11] Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
    Plitt, Anna
    Ruff, Christian T.
    Giugliano, Robert P.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (05) : 1019 - +
  • [12] Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
    Nielsen, Peter Bronnum
    Skjoth, Flemming
    Sogaard, Mette
    Kjaeldgaard, Jette Nordstrom
    Lip, Gregory Y. H.
    Larsen, Torben Bjerregaard
    STROKE, 2019, 50 (04) : 939 - 946
  • [13] Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation
    Farinha, Jose Maria
    Jones, Ian D.
    Lip, Gregory Y. H.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 : A42 - A55
  • [14] Selection bias in studies of non-vitamin K antagonist oral anticoagulant users with atrial fibrillation
    Hellfritzsch, Maja
    Grove, Erik L.
    Haastrup, Simone B.
    Rasmussen, Lotte
    Pottegard, Anton
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 108 - 108
  • [15] Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
    Undas, Anetta
    Drabik, Leszek
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2020, 23 (01): : 10 - 18
  • [16] Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Thrombocytopenia
    Janion-Sadowska, Agnieszka
    Papuga-Szela, Elbieta
    Lukaszuk, Robert
    Chrapek, Magdalena
    Undas, Anetta
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2018, 72 (03) : 153 - 160
  • [17] Cessation of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
    Middeldorp, Melissa E.
    Gupta, Aashray
    Elliott, Adrian
    Kadhim, Kadhim
    Thiyagarajah, Anand
    Gallagher, Celine
    Hendriks, Jeroen
    Linz, Dominik
    Emami, Mehrdad
    Mahajan, Rajiv
    Lau, Dennis
    Sanders, Prashanthan
    HEART, 2021, 107 (12) : 971 - 976
  • [18] Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage
    Tsai, Chuan-Tsai
    Liao, Jo-Nan
    Chiang, Chern-En
    Lin, Yenn-Jiang
    Chang, Shih-Lin
    Lo, Li-Wei
    Hu, Yu-Feng
    Tuan, Ta-Chuan
    Chung, Fa-Po
    Chao, Tze-Fan
    Lip, Gregory Y. H.
    Chen, Shih-Ann
    JAMA NETWORK OPEN, 2020, 3 (06) : E206424
  • [19] Risk of dementia in patients treated with non-vitamin k antagonist oral anticoagulant or warfarin for nonvalvular atrial fibrillation
    Kim, D.
    Yang, P. S.
    Jang, E.
    Yu, H. T.
    Kim, T. H.
    Uhm, J. S.
    Kim, J. Y.
    Sung, J. H.
    Pak, H. N.
    Lee, M. H.
    Lip, G. Y. H.
    Joung, B.
    EUROPEAN HEART JOURNAL, 2019, 40 : 12 - 12
  • [20] Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation
    Lee, Hsin-Fu
    Chan, Yi-Hsin
    Chang, Shang-Hung
    Tu, Hui-Tzu
    Chen, Shao-Wei
    Yeh, Yung-Hsin
    Wu, Lung-Sheng
    Kuo, Chang-Fu
    Kuo, Chi-Tai
    See, Lai-Chu
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (05):
12345